Worst performer was BLU:Blue Star Capital dropping 13% but nothing unusual about that as it goes up and down like a yo-yo, but as the spread is 18% there's no way to take advantage in the short term.
SBTX:SkinBioTherapeutics proves the curse of the trading account, as
I only got a small volume in there last week but a lackluster trading
statement sent the shares down 13%. My recent £5,000 investment is already
losing £1,292 as yet again I get it completely wrong.
CWR:Ceres Power continues the abject misery after declaring the the
JV money isn't going to come in this trading year. The price dropped another
12% to go 42% down in about a month.
KIBO:Kibo Energy is a heap of rubbish and fell 11% but it's academic
as they are already 100% down.
AJB:AJ Bell is another of my recent investments and dropped 8% this
week. However, as I'll be investing monthly for 3 more months, I don't
mind if these drop for a while so I get cheaper shares.
FXPO:Ferrexpo fell 7% for no reason.
IES:Invinity Energy also fell 7% for no reason.
Normally I save the biggest riser till last, but
SAE:Simec Atlantis Energy climbing 22% is utterly meaningless so
I'm getting it out of the way first. My holding is still 87% down.
The only meaningful big risers were metals and mainly gold.
ANTO:Antofagasta rose 5% possibly on the back of copper supply
reducing due to problems at one of the world's biggest mines. Strange how
that boosted ANTO but not CAML:Central Asia Metals.
POLY:Polymetal climbed 8%, EDV:Endeavour Mining climbed 10%
and CEY:Centamin wins Share of the Week climbing 11% as gold had a
great rally.
Here's the ISA and shares portfolio after week 18 of year 9.
| Weekly Change | |||
| Cash | £165.60 | +£0 | |
| Portfolio cost | £99,082.34 | +£0 | |
|
Portfolio sell value (bid price-commission) |
£49,696.98 | (-49.8%) | -£1,249.55 |
| Potential profits | £2,147.02 | -£127.69 | |
| Yr 9 Dividends | £147.01 | +£0 | |
| Yr 9 Interest | £2.46 | +£0 | |
| Yr 9 Profit from sales | £0 | +£0 | |
| Yr 9 proj avg monthly profit | £29.42 | (0.5%) | -£1.73 |
| Total Dividends | £12,058.44 | +£0 | |
| Total Interest | £4.39 | +£0 | |
| Total Profit from sales | £17,298.53 | +£0 | |
| Average monthly cash profit | £289.11 | (4.9%) | -£0.67 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 41% | +0% |
Very little happened. Portfolio value dropped and potential profits down thanks to OPTI:Optibiotix losing 0.5p. Value is down by nearly 50% so I'll have to switch to crimson next week unless we get a turnaround.
The decline has been going on a worrying number of weeks.
Well below the trend line now, so it's getting pulled flatter.
The SIPP looks like this after week 418 overall and week 2 of year 9.
| Weekly Change | ||||
| Cash | £324.37 | -£103.95 | ||
| Portfolio cost | £101,147.82 | +£1,466.88 | ||
|
Portfolio sell value (bid price - commission) |
£54,946.72 | (-45.7%) | -£1,867.60 | |
| Potential profits | £2,340.02 | -£1,393.29 | ||
| Yr 9 Dividends | £13.99 | +£0 | ||
| Yr 9 Interest | £0 | +£0 | ||
| Yr 9 Profit from sales | £1,362.94 | +£1,362.94 | ||
| Yr 9 proj avg monthly profit | £2,983.34 | (52.6%) | +£2,983.34 | |
| Total Dividends | £14,648.87 | +£0 | ||
| Total Interest | £5.93 | +£0 | ||
| Total Profit from sales | £12,198.84 | +£1,362.94 | ||
| Average monthly cash profit | £266.39 | (4.7%) | +£13.53 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 38% | +2% |
Lots going on here. I started off selling my small holding in EDV:Endeavour Mining in my AJ Bell SIPP because I wanted to invest in PAF:Pan African Resources before their dividend date. I sold my 31 shares at 1766.3643 making £52.37 (11.1%) profit. I used the proceeds to buy 3,471 shares in PAF:Pan African Resources at 16.9133p costing £599.95.
I also decided to sell some of my cheap OPTI:Optibiotix shares so I
could show a profit. I sold 8,000 at 26.24p after buying at 9.56p and made
£1,310.57 (166.1%) profit, liberating £2,087.
Half of it went on more PAF:Pan African Resources. I bought 5,771
but the price had gone up to 17.3278p. That cost £1,016.94. Happy to say
the sell price is 17.4p despite going ex-dividend, so these are only down
my commission. Let's hope gold stays at the current levels for a while.
The other half of the proceeds went on more JLP:Jubilee Metals as
I'm hoping they have finally reached the bottom. I'm still bewildered how
they dropped so low. I bought 21,568 at 5.1p costing £1,111.92. The sell
price is now up to 5.1p so these are just down on commission. I now hold
213,181 JLP shares, making it my 2nd biggest holding after
OPTI:Optibiotix. My hope is that I can take profits and invest them
in bigger dividend paying miners in my SIPP and leave the ISA in
JLP longer term. I do really need to start moving my SIPP holdings
into dividend playing shares and leave the ISA for more risky
investments.
The result of the selling activity was a meagre £13 (0.2%) a month increase in long term performance, showing how much profit needs to be made if I want to get back to my 10% target from 4.7%.
I'm less concerned about this chart than the ISA, although it's still pretty bad.
And so we cross the trend line - bugger!
The trading account looks like this after week 384 overall and week 20 of year 8.
Hardly any change here, with a drop of £8 in value mostly down to SBTX:SkinBioTherapeutics.
Looking very flat
No sign of getting back above the trend line.
The result of the selling activity was a meagre £13 (0.2%) a month increase in long term performance, showing how much profit needs to be made if I want to get back to my 10% target from 4.7%.
I'm less concerned about this chart than the ISA, although it's still pretty bad.
And so we cross the trend line - bugger!
The trading account looks like this after week 384 overall and week 20 of year 8.
| Weekly Change | |||
| Cash | £141.20 | +£0 | |
| Portfolio cost | £1,935.11 | +£0 |
|
|
Portfolio sell value (bid price - commission) |
£1,089.33 | (-43.7%) | -£8.17 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £8.56 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £63.38 | (+39.3%) | -£3.34 |
| Dividends | £68.66 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.52 | (-4.0%) | +£0.02 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Hardly any change here, with a drop of £8 in value mostly down to SBTX:SkinBioTherapeutics.
Looking very flat
No sign of getting back above the trend line.
It felt great to finally make some profit from my
OPTI:Optibiotix holding. Granted it nowhere near makes up for the
£56k loss I'm sitting on, in fact it makes that worse, but it is making a
start in my strategy to move SIPP shares into dividend-paying companies.
At the current rate I have another £1.5k potential profit in my SIPP which
would liberate £2.5k for dividend paying shares and not dent my
OPTI holding by too much. That would make sense from a risk
management point of view, but I'll probably wait until I can liberate
£3k.
No comments:
Post a Comment